Stock exchange intimation

Stock Exchange Intimation

Filter:

31 Jul 2026 – Intimation of transcript of Earnings Call dated July 25, 2026
24 Jul 2026 – Intimation for allotment of shares pursuant to OneSource ESOP Scheme 2021
24 Jul 2026 – Intimation for resignation of Senior Management Personnel effective July 24, 2026
24 Jul 2026 – Intimation of Outcome of Board Meetings dated July 24, 2026 for approval of Standalone and Consolidated financial results for the quarter ended June 30, 2026
24 Jul 2026 – OneSource announces strong Q1FY27 results Revenue up 37% YoY and EBITDA up 39% YoY
21 Jul 2026 – Intimation regarding Q1FY27 Earnings Call
14 Jul 2026 – OneSource Specialty Pharma and Formycon AG announce Strategic Manufacturing Partnership for Biosimilars
9 Jul 2026 – Intimation Under Regulation 30 – Clarification regarding delay in commercial supplies of Semaglutide.
8 Jul 2026 – Intimation for: Allotment of shares pursuant to OneSource ESOP Scheme 2021
2 Jul 2026 – Completion of US-FDA Inspection at Sterile Product Division facility at Bengaluru
24 Jun 2026 – Intimation of closure of Trading window for declaration of unaudited financial results for the quarter ended June 30, 2026
19 May 2026 – In furtherance to the intimation dated May 13, 2026, w.r.t the resignation of SMP, please find enclosed the resignation document
19 May 2026 – Intimation of Transcript of Earnings call dated May 13, 2026
16 May 2026 – Government of Karnataka has accorded in-principle approval for the application submitted by the Company for Unit-II expansion project under the Karnataka Industrial Policy (KIP) 2025-30, towards incentives and concessions
14 May 2026 – Intimation about publication of newspaper advertisement – Extract of Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026